Allergy Origens


an·a·phy·lax·is, noun:
an acute allergic reaction to an antigen (e.g., a bee sting) to which the body has become hypersensitive.


To fully understand this term, we need to go back almost 100 years. The story begins on a cruise aboard Prince Albert I of Monaco’s yacht. The prince had invited two Parisian scientists to perform studies on the toxin produced by the tentacles of a local jellyfish, the Portuguese Man of War. Charles Richet and Paul Portier were able to isolate the toxin and tried to vaccinate dogs in the hope of obtaining protection, or “prophylaxis,” against the toxin. They were horrified to find that subsequent very small doses of the toxin unexpectedly resulted in a new dramatic illness that involved the rapid onset of breathing difficulty and resulted in death within 30 minutes. Richet and Portier termed this “anaphylaxis” or “against protection.” They rightly concluded that the immune system first becomes sensitized to the allergen over several weeks and upon reexposure to the same allergen may result in a severe reaction. An allergen is a substance that is foreign to the body and can cause an allergic reaction in certain people. Charles Richet was awarded the Nobel Prize in 1913 for his work on anaphylaxis.

✳Anaphylaxis was coined to describe a vaccine injury! What do we inject today that our bodies could be reacting to? Becoming sensitized and trained to react to as invaders? Eggs. Casein. Gluten. Soy. Peanut. MSG. Cow. Pig. Monkey. Dog. Horse. Insect. Formaldehyde. Antibiotics. Latex. All ingredients or contaminants in modern day vaccines.

✳Check out this chart to help you identify some of the ways they may be listed on package inserts:

✳A few citations that show links of allergies and asthma to vaccinations:

🔹M.R. Nelson, et al., “Anaphylaxis complicating routine childhood immunization: haemophilus influenza b conjugated vaccine,” Pediatric Asthma, Allergy & Immunology, 14, 4 (Dec. 2000): 315-321.
🔹M. Flora Martin-Munoz, “Anaphylactic reaction to diphtheria-tetanus vaccine in a chid: specific IgE IgG determinations and cross-reactivity studies,” Vaccine, 20, 27-38 (Sept. 2002): 3409-3412.
🔹U. Kosecka, et al. “Pertussis adjuvant prolongs intestinal hypersensitivity, “ International Archives of Allergy & Immunology, 119, 3 (July, 1999): 205-11.
🔹Nakayama T, Aizawa C, Kuno-Sakai H. “A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids,” Journal of Allergy & Clinical Immunolology (Feb., 1999): 321-5.
🔹H. Kuno-Sakai, M. Kimura, “Removal of gelatin from live vaccines and DTaP – an ultimate solution for vaccine-related gelatin allergy,” Biologicals, 31 (2003): 245-249.
🔹V. Pool, et al. “Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps-rubella vaccine in the United States,” Pediatrics, 110, 6 (Dec. 2002): e71.
🔹M.R. Hilleman, et al., “Imunological Adjuvants Report of a WHO Scientific Group”, World Health Organization Technical Report Series, No. 5959 (Geneva, WHO, 1976) 11.
🔹Compares vaccinated to unvaccinated:

✳Further reading: